Nagpur cyclotron project: Maharashtra cabinet clears ₹300 crore cancer care hub
Synopsis
Key Takeaways
The Maharashtra cabinet, chaired by Chief Minister Devendra Fadnavis, on Tuesday, 16 June approved the establishment of a High-Energy Medical Cyclotron Project (HEMCP) in Nagpur at an estimated cost of ₹300 crore. The decision is expected to significantly improve access to advanced cancer diagnostics and treatment for patients across Central India, reducing dependence on distant medical hubs such as Mumbai and Hyderabad.
What the Project Entails
The HEMCP will transform Nagpur into a Radiopharmaceutical Innovation Hub, ensuring local availability of critical radioisotopes required for PET-CT and Nuclear Medicine services. A 30-hectare land parcel at Bhansoli (Kinhi) in Hingna taluka has been earmarked for the facility.
Funding will be shared equally between the Medical Education Department and the Industry Department on a 50:50 basis. The Medical Education Department will immediately release ₹150 crore as its initial contribution, according to the government release.
Execution and Governance Structure
The project will be executed through Mahacare, a dedicated Special Purpose Vehicle (SPV) incorporated under the Companies Act, 2013. Until the SPV is formally constituted, a steering committee chaired by Shrikar Pardeshi, Principal Secretary to the Chief Minister, will oversee operations and planning.
Notably, this institutional framework mirrors the state's approach to other large-scale health infrastructure projects, aiming to insulate execution from bureaucratic delays.
Who Will Benefit and Why Nagpur
Nagpur's central geographical position makes it a natural distribution point for radiopharmaceuticals. The facility is projected to serve patients within a 500-kilometre radius, covering Maharashtra, Madhya Pradesh, Chhattisgarh, Telangana, and Andhra Pradesh. It will leverage the existing healthcare ecosystem anchored by AIIMS Nagpur, the National Cancer Institute (NCI), and the Government Medical College (GMC).
This comes amid growing concern over the unequal distribution of nuclear medicine infrastructure in India, where PET-CT facilities remain heavily concentrated in metropolitan centres, leaving patients in Tier-2 and Tier-3 cities travelling hundreds of kilometres for diagnosis.
Cabinet Also Clears Rural Water Policy
In a separate decision, the cabinet approved the Maharashtra Rural Drinking Water Policy 2026, aimed at delivering sustainable, clean drinking water to rural households in line with the Viksit Maharashtra 2047 vision.
The policy creates a master plan for operations and maintenance of water schemes under Jal Jeevan Mission 2.0, with a central corpus fund at the Gram Panchayat, Zilla Parishad, and Maharashtra Jeevan Pradhikaran (MJP) levels. Monthly water tariffs for households have been capped between ₹150 and ₹400. SCADA systems, a GIS-based grievance dashboard, and the Nal Jal Seva mobile application will support real-time monitoring.
Priority for billing, collection, and maintenance contracts will be given to local Women Self-Help Groups (SHGs) and Primary Agricultural Credit Societies (PACS), with a three-tier Grievance Redressal Cell to handle complaints.
What Comes Next
With land already identified and the initial ₹150 crore allocation in place, the Mahacare SPV's formal constitution is the immediate next milestone. Industry observers will watch whether the project's execution timeline matches the ambition — radiopharmaceutical infrastructure typically requires stringent regulatory clearances from the Atomic Energy Regulatory Board (AERB) before commissioning.